DORA PSI | Digital Object Repository at PSI

Export As:

Style

Style

Search Results 1 - 20 of 35

Sort

	Select Page
	Investigations using albumin binders to modify the tissue distribution profile of radiopharmaceuticals exemplified with folate radioconjugates Busslinger, S. D., Becker, A. E., Vaccarin, C., Deberle, L. M., Renz, M. L., Groehn, V., … Müller, C. (2023). Investigations using albumin binders to modify the tissue distribution profile of radiopharmaceuticals exemplified with folate radioconjugates. Cancers, 15(17), 4259 (19 pp.). https://doi.org/10.3390/cancers15174259 Detailed Record Published Version
	Design and evaluation of novel albumin-binding folate radioconjugates: systematic approach of varying the linker entities Benešová, M., Guzik, P., Deberle, L. M., Busslinger, S. D., Landolt, T., Schibli, R., & Müller, C. (2022). Design and evaluation of novel albumin-binding folate radioconjugates: systematic approach of varying the linker entities. Molecular Pharmaceutics, 19, 963-973. https://doi.org/10.1021/acs.molpharmaceut.1c00932 Detailed Record Published Version Accepted Version
	Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates - new perspectives for folate receptor-targeted radionuclide therapy Guzik, P., Benešová, M., Ratz, M., Monné Rodríguez, J. M., Deberle, L. M., Schibli, R., & Müller, C. (2021). Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates - new perspectives for folate receptor-targeted radionuclide therapy. European Journal of Nuclear Medicine and Molecular Imaging, 48, 972-983. https://doi.org/10.1007/s00259-020-04980-y Detailed Record Published Version
	Promising potential of [<sup>177</sup>Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy - a preclinical study using a syngeneic breast cancer model Guzik, P., Siwowska, K., Fang, H. Y., Cohrs, S., Bernhardt, P., Schibli, R., & Müller, C. (2021). Promising potential of [¹⁷⁷Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy - a preclinical study using a syngeneic breast cancer model. European Journal of Nuclear Medicine and Molecular Imaging, 48, 984-994. https://doi.org/10.1007/s00259-020-05054-9 Detailed Record Published Version
	Radiation dosimetry of <sup>18</sup>F-AzaFol: a first in-human use of a folate receptor PET tracer Gnesin, S., Müller, J., Burger, I. A., Meisel, A., Siano, M., Früh, M., … Schaefer, N. (2020). Radiation dosimetry of ¹⁸F-AzaFol: a first in-human use of a folate receptor PET tracer. EJNMMI Research, 10(1), 32 (12 pp.). https://doi.org/10.1186/s13550-020-00624-2 Detailed Record Published Version
	Diastereomerically pure 6<em>R</em>- and 6<em>S</em>-3'-aza-2'-<sup>18</sup>F-fluoro-5-methyltetrahydrofolates show unprecedentedly high uptake in folate receptor-positive KB tumors Boss, S. D., Müller, C., Siwowska, K., Schmid, R. M., Groehn, V., Schibli, R., & Ametamey, S. M. (2019). Diastereomerically pure 6R- and 6S-3'-aza-2'-¹⁸F-fluoro-5-methyltetrahydrofolates show unprecedentedly high uptake in folate receptor-positive KB tumors. Journal of Nuclear Medicine, 60(1), 135-141. https://doi.org/10.2967/jnumed.118.213314 Detailed Record Published Version
	Combination of proton therapy and radionuclide therapy in mice: preclinical pilot sudy at the Paul Scherrer Institute Müller, C., De Prado Leal, M., Dominietto, M. D., Umbricht, C. A., Safai, S., Perrin, R. L., … Lomax, A. J. (2019). Combination of proton therapy and radionuclide therapy in mice: preclinical pilot sudy at the Paul Scherrer Institute. Pharmaceutics, 11(9), 450 (13 pp.). https://doi.org/10.3390/pharmaceutics11090450 Detailed Record Published Version
	<sup>18</sup>F-AzaFol for detection of folate receptor-β positive macrophages in experimental interstitial lung disease - a proof-of-concept study Schniering, J., Benešová, M., Brunner, M., Haller, S., Cohrs, S., Frauenfelder, T., … Maurer, B. (2019). ¹⁸F-AzaFol for detection of folate receptor-β positive macrophages in experimental interstitial lung disease - a proof-of-concept study. Frontiers in Immunology, 10, 2724 (15 pp.). https://doi.org/10.3389/fimmu.2019.02724 Detailed Record Published Version
	Therapeutic potential of <sup>47</sup>Sc in comparison to <sup>177</sup>Lu and <sup>90</sup>Y: preclinical investigations Siwowska, K., Guzik, P., Domnanich, K. A., Monné Rodríguez, J. M., Bernhardt, P., Ponsard, B., … Müller, C. (2019). Therapeutic potential of ⁴⁷Sc in comparison to ¹⁷⁷Lu and ⁹⁰Y: preclinical investigations. Pharmaceutics, 11(8), 424 (13 pp.). https://doi.org/10.3390/pharmaceutics11080424 Detailed Record Published Version
	Folate receptor-positive gynecological cancer cells: in vitro and in vivo characterization Siwowska, K., Schmid, R. M., Cohrs, S., Schibli, R., & Müller, C. (2017). Folate receptor-positive gynecological cancer cells: in vitro and in vivo characterization. Pharmaceuticals, 10(3), 72 (17 pp.). https://doi.org/10.3390/ph10030072 Detailed Record Published Version
	<sup>64</sup>Cu- and <sup>68</sup>Ga-based PET imaging of folate receptor-positive tumors: development and evaluation of an albumin-binding NODAGA−folate Farkas, R., Siwowska, K., Ametamey, S. M., Schibli, R., van der Meulen, N. P., & Müller, C. (2016). ⁶⁴Cu- and ⁶⁸Ga-based PET imaging of folate receptor-positive tumors: development and evaluation of an albumin-binding NODAGA−folate. Molecular Pharmaceutics, 13(6), 1979-1987. https://doi.org/10.1021/acs.molpharmaceut.6b00143 Detailed Record Published Version
	Preclinical development of small-molecular-weight folate-based radioconjugates: a pharmacological perspective Siwowska, K., & Müller, C. (2015). Preclinical development of small-molecular-weight folate-based radioconjugates: a pharmacological perspective. Quarterly Journal of Nuclear Medicine and Molecular Imaging, 59(3), 269-286. Detailed Record Published Version
	Direct in vitro and in vivo comparison of <sup>161</sup>Tb and <sup>177</sup>Lu using a tumour-targeting folate conjugate Müller, C., Reber, J., Haller, S., Dorrer, H., Bernhardt, P., Zhernosekov, K., … Schibli, R. (2014). Direct in vitro and in vivo comparison of ¹⁶¹Tb and ¹⁷⁷Lu using a tumour-targeting folate conjugate. European Journal of Nuclear Medicine and Molecular Imaging, 41(3), 476-485. https://doi.org/10.1007/s00259-013-2563-z Detailed Record Published Version
	Folate receptor targeted alpha-therapy using terbium-149 Müller, C., Reber, J., Haller, S., Dorrer, H., Köster, U., Johnston, K., … Schibli, R. (2014). Folate receptor targeted alpha-therapy using terbium-149. Pharmaceuticals, 7(3), 353-365. https://doi.org/10.3390/ph7030353 Detailed Record Published Version
	Promising prospects for <sup>44</sup>Sc-/<sup>47</sup>Sc-based theragnostics: application of <sup>47</sup>Sc for radionuclide tumor therapy in mice Müller, C., Bunka, M., Haller, S., Köster, U., Groehn, V., Bernhardt, P., … Schibli, R. (2014). Promising prospects for ⁴⁴Sc-/⁴⁷Sc-based theragnostics: application of ⁴⁷Sc for radionuclide tumor therapy in mice. Journal of Nuclear Medicine, 55(10), 1658-1664. https://doi.org/10.2967/jnumed.114.141614 Detailed Record Published Version
	Improved PET imaging of tumors in mice using a novel <sup>18</sup>F-folate conjugate with an albumin-binding entity Fischer, C. R., Groehn, V., Reber, J., Schibli, R., Ametamey, S. M., & Müller, C. (2013). Improved PET imaging of tumors in mice using a novel ¹⁸F-folate conjugate with an albumin-binding entity. Molecular Imaging and Biology, 15(6), 649-654. https://doi.org/10.1007/s11307-013-0651-x Detailed Record Published Version
	DOTA conjugate with an albumin-binding entity enables the first folic acid-targeted <sup>177</sup>Lu-radionuclide tumor therapy in mice Müller, C., Struthers, H., Winiger, C., Zhernosekov, K., & Schibli, R. (2013). DOTA conjugate with an albumin-binding entity enables the first folic acid-targeted ¹⁷⁷Lu-radionuclide tumor therapy in mice. Journal of Nuclear Medicine, 54(1), 124-131. https://doi.org/10.2967/jnumed.112.107235 Detailed Record Published Version
	Folate-based radiotracers for PET imaging - update and perspectives Müller, C. (2013). Folate-based radiotracers for PET imaging - update and perspectives. Molecules, 18(5), 5005-5031. https://doi.org/10.3390/molecules18055005 Detailed Record Published Version
	Promises of cyclotron-produced <sup>44</sup>Sc as a diagnostic match for trivalent β<sup>-</sup>-emitters: in vitro and in vivo study of a <sup>44</sup>Sc-DOTA-folate conjugate Müller, C., Bunka, M., Reber, J., Fischer, C., Zhernosekov, K., Türler, A., & Schibli, R. (2013). Promises of cyclotron-produced ⁴⁴Sc as a diagnostic match for trivalent β^--emitters: in vitro and in vivo study of a ⁴⁴Sc-DOTA-folate conjugate. Journal of Nuclear Medicine, 54(12), 2168-2174. https://doi.org/10.2967/jnumed.113.123810 Detailed Record Published Version
	Prospects in folate receptor-targeted radionuclide therapy Müller, C., & Schibli, R. (2013). Prospects in folate receptor-targeted radionuclide therapy. Frontiers in Oncology, 3, 249 (10 pp.). https://doi.org/10.3389/fonc.2013.00249 Detailed Record Published Version